The trading day ended on a positive note for international stocks in New York. The S&P/BNY Mellon index of American depositary receipts witnessed a significant 2% increase, reaching a high of 156.16. Similarly, the European index saw a positive trend with a 1.9% rise to 150.29. Asia also experienced a boost with the Asian index rising by 2.2% to 181.67. Latin American stocks showed a slight improvement as the Latin American index edged up by 0.6% to 205.65. The emerging-markets index rose by 2% to reach an impressive 303.41.
RedHill Biopharma stood out among actively traded ADRs during the day. The specialty biopharmaceutical company witnessed a staggering 27% surge in its stock price following its latest earnings report. The report highlighted a nearly 10% increase in new prescriptions of Talicia compared to the previous year. Dror Ben-Asher, Chief Executive of RedHill Biopharma, expressed optimism for the company’s future commercial endeavors, particularly focusing on maximizing the potential of Talicia.
EHang Holdings also experienced an upward trend in its stock price, as it climbed a remarkable 20%. This surge came after the announcement that the autonomous aerial vehicle technology platform company successfully secured a $23 million private placement through share subscription agreements with several strategic investors.
Overall, this bullish trading session indicates positive prospects for international stocks, as various sectors and regions demonstrated notable gains. Investors eagerly await further developments in these companies and their respective markets.